PL209080A1 - Sposob wytwarzania soli sodowej pochodnej oksiminowej kwasu 7-aminotiazoliloacetamido-cefalosporanowego w postaci krystalicznej - Google Patents

Sposob wytwarzania soli sodowej pochodnej oksiminowej kwasu 7-aminotiazoliloacetamido-cefalosporanowego w postaci krystalicznej

Info

Publication number
PL209080A1
PL209080A1 PL20908078A PL20908078A PL209080A1 PL 209080 A1 PL209080 A1 PL 209080A1 PL 20908078 A PL20908078 A PL 20908078A PL 20908078 A PL20908078 A PL 20908078A PL 209080 A1 PL209080 A1 PL 209080A1
Authority
PL
Poland
Prior art keywords
aminothiazolylacetamide
oximine
derivative
making
sodium salt
Prior art date
Application number
PL20908078A
Other languages
English (en)
Other versions
PL126619B1 (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9194564&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL209080(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PL209080A1 publication Critical patent/PL209080A1/pl
Publication of PL126619B1 publication Critical patent/PL126619B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1978209080A 1977-08-17 1978-08-16 Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form PL126619B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7725142A FR2400519A1 (fr) 1977-08-17 1977-08-17 Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament

Publications (2)

Publication Number Publication Date
PL209080A1 true PL209080A1 (pl) 1979-06-04
PL126619B1 PL126619B1 (en) 1983-08-31

Family

ID=9194564

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1978209080A PL126619B1 (en) 1977-08-17 1978-08-16 Method for producing natrium salt of oximine derivative of 7-aminothiazolylacetamidocephalosporanic acid in a rew hydrated cristalline form

Country Status (34)

Country Link
US (1) US4224371A (pl)
EP (1) EP0001024B1 (pl)
JP (1) JPS5441890A (pl)
AT (2) AT366049B (pl)
AU (1) AU520898B2 (pl)
BG (2) BG33887A3 (pl)
CA (1) CA1121343A (pl)
CS (2) CS207646B2 (pl)
DD (1) DD137588A5 (pl)
DE (1) DE2860358D1 (pl)
DK (2) DK152213C (pl)
EG (1) EG13520A (pl)
ES (1) ES472381A1 (pl)
FI (1) FI65433C (pl)
FR (1) FR2400519A1 (pl)
GE (2) GEP19960476B (pl)
GR (1) GR73661B (pl)
HR (1) HRP931395B1 (pl)
HU (1) HU181497B (pl)
IE (1) IE47230B1 (pl)
IL (1) IL55186A (pl)
IT (1) IT1107961B (pl)
MD (2) MD247C2 (pl)
MX (2) MX155976A (pl)
NO (1) NO156168C (pl)
NZ (1) NZ188163A (pl)
OA (1) OA06016A (pl)
PL (1) PL126619B1 (pl)
PT (1) PT68431A (pl)
RO (1) RO79999A (pl)
SI (1) SI7811917A8 (pl)
SU (2) SU799666A3 (pl)
YU (1) YU42166B (pl)
ZA (1) ZA784187B (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
EP0150507B1 (en) * 1983-12-29 1992-08-05 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives, processes for producing the same and compositions containing them
JPS60142987A (ja) * 1983-12-29 1985-07-29 Mochida Pharmaceut Co Ltd セフアロスポリン誘導体
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
WO1987001117A2 (en) * 1985-08-12 1987-02-26 The Upjohn Company Conversion of cephalosporin hydrohalide salt to alkali metal salt
US4880798A (en) * 1986-11-25 1989-11-14 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
JPS63132893A (ja) * 1986-11-25 1988-06-04 Mochida Pharmaceut Co Ltd 新規セフアロスポリン誘導体、その製法およびそれらを有効成分とする抗菌剤
RU2021274C1 (ru) 1991-05-17 1994-10-15 Польска Акадэмия Наук Институт Хэмии Органичнэй Способ получения аминотиазолильных производных цефалоспорина
US5318781A (en) * 1993-04-06 1994-06-07 Hoffmann-La Roche Inc. Absorption enhancement of antibiotics
US5574154A (en) * 1994-09-29 1996-11-12 Alnejma Bulk Pharmaceutical Co. A.B.P.C. Process for the preparation of cephalosporanic compounds
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
AT402928B (de) * 1994-12-23 1997-09-25 Biochemie Gmbh Neues verfahren zur herstellung von cefotaxim
AU690482B2 (en) * 1996-03-18 1998-04-23 Ranbaxy Laboratories Limited Process for producing cephalosporin antibiotics
GB9717629D0 (en) * 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents
WO2001092254A1 (en) * 2000-05-30 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. Method for replacing organic solvents contained in clathrate crystals
WO2004063203A1 (en) * 2003-01-10 2004-07-29 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cefotaxime sodium
CN100361995C (zh) * 2004-10-27 2008-01-16 山东瑞阳制药有限公司 注射级无菌头孢噻肟钠的一步法制备工艺

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3970651A (en) * 1974-01-07 1976-07-20 Bristol-Myers Company Crystalline cephalosporin derivative
US3985747A (en) * 1974-05-24 1976-10-12 Bristol-Myers Company Crystalline sesquihydrate of 7-[D-α-amino-α-(p-hydroxyphenyl)acetamido]-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4006138A (en) * 1975-04-11 1977-02-01 Eli Lilly And Company Crystalline form of sodium O-formylcefamandole
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
SE440655B (sv) * 1976-01-23 1985-08-12 Roussel Uclaf Sett att framstella nya oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra

Also Published As

Publication number Publication date
FI782494A7 (fi) 1979-02-18
NZ188163A (en) 1981-10-19
HU181497B (en) 1983-07-28
AT366049B (de) 1982-03-10
DE2860358D1 (en) 1981-03-12
SI7811917A8 (en) 1997-12-31
YU191778A (en) 1983-02-28
EP0001024B1 (fr) 1981-01-21
MX155976A (es) 1988-06-06
NO156168B (no) 1987-04-27
JPS6145626B2 (pl) 1986-10-08
IL55186A (en) 1981-07-31
GR73661B (pl) 1984-03-28
AU520898B2 (en) 1982-03-04
DK159786A (da) 1986-04-09
DK152213C (da) 1988-07-11
RO79999A (ro) 1982-10-11
ATA563578A (de) 1981-07-15
GEP19960476B (en) 1996-07-22
CA1121343A (fr) 1982-04-06
AT366050B (de) 1982-03-10
DD137588A5 (de) 1979-09-12
EP0001024A1 (fr) 1979-03-07
PL126619B1 (en) 1983-08-31
DK159786D0 (da) 1986-04-09
DK361078A (da) 1979-02-18
CS207646B2 (en) 1981-08-31
DK163514B (da) 1992-03-09
FI65433B (fi) 1984-01-31
SU852175A3 (ru) 1981-07-30
ZA784187B (en) 1979-09-26
HRP931395B1 (en) 1996-04-30
AU3896578A (en) 1980-02-21
DK152213B (da) 1988-02-08
JPS5441890A (en) 1979-04-03
SU799666A3 (ru) 1981-01-23
ATA52280A (de) 1981-07-15
MD225B1 (ro) 1995-06-30
FR2400519A1 (fr) 1979-03-16
MX5448E (es) 1983-08-09
IL55186A0 (en) 1978-09-29
PT68431A (fr) 1978-09-01
IT1107961B (it) 1985-12-02
FI65433C (fi) 1984-05-10
GEP19960475B (en) 1996-07-22
BG33888A3 (bg) 1983-05-16
YU42166B (en) 1988-06-30
ES472381A1 (es) 1979-03-16
MD247C2 (ro) 1995-12-31
NO156168C (no) 1987-08-19
MD225C2 (ro) 1995-12-31
IT7850648A0 (it) 1978-08-08
NO782782L (no) 1979-02-20
IE47230B1 (en) 1984-01-25
FR2400519B1 (pl) 1980-05-16
MD247B1 (ro) 1995-07-31
DK163514C (da) 1992-07-27
OA06016A (fr) 1981-06-30
BG33887A3 (bg) 1983-05-16
US4224371A (en) 1980-09-23
IE781669L (en) 1979-02-17
CS207647B2 (en) 1981-08-31
EG13520A (en) 1982-03-31

Similar Documents

Publication Publication Date Title
PL209080A1 (pl) Sposob wytwarzania soli sodowej pochodnej oksiminowej kwasu 7-aminotiazoliloacetamido-cefalosporanowego w postaci krystalicznej
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
PL209188A1 (pl) Sposob wytwarzania 1-fenylo-2-azalilo-4,4-dwumetylopenten-1-ali-3 i ich soli
PL207396A1 (pl) Sposob wytwarzania nowych pochodnych kwasu penicylanowego
PL204747A1 (pl) Sposob wytwarzania kwasu d,1-5-metyloczterowodorofoliowego oraz jego soli
IT1162442B (it) Procedimento per preparare il sale sodico di cefurossima in forma cristallina
JPS5479226A (en) Method of obtaining asparagic acid salt
PL209256A1 (pl) Sposob wytwarzania pochodnych kwasu 2-hydrazonopropionowego
UA8370A1 (uk) Спосіб одержання n2-арілсульфоніл-l-аргінінамідів або їх солей
IT1102458B (it) Procedimento per la produzione di ditionito sodico
PL204551A1 (pl) Sposob wytwarzania nowych pochodnych kwasu benzoheterocykloglioksalowego
PL193714A1 (pl) Sposob wytwarzania soli sodowej kwasu 1-amino-4-bromoantrachinono-2-sulfonowego
PL205586A1 (pl) Sposob wytwarzania pochodnych kwasu oksazolinoazetydynylopentenylowego
PL210157A1 (pl) Sposob wytwarzania nowych pochodnych kwasow aryloalkanokarboksylowych
PL204862A1 (pl) Sposob otrzymywania soli dwusodowej monoestrow kwasu sulfobursztynowego
PL204590A1 (pl) Sposob wytwarzania pochodnych kwasu 2-metylo-2-fenoksypropionowego
PL196858A1 (pl) Sposob wytwarzania soli cynkowej kwasu etylenobisdwutiokarbaminowego
PL204553A1 (pl) Sposob wytwarzania nowych pochodnych kwasu inolilogliksalowego
KR780000599B1 (en) Method for crystallization of sodium salt of 5'-inosinic acid
PL204065A1 (pl) Sposob wytwarzania nowych pochodnych kwasu amino-cykloalkanopenamokarboksylowego
PL190961A1 (pl) Sposob otrzymywania soli dwusodowej penicyliny alfa-karboksybenzylowej
PL205039A1 (pl) Sposob wytwarzania kompozycji nieorganicznych soli sodowych
PL197138A1 (pl) Sposob wytwarzania nowych oksymow pochodnych kwasu 7-amino-tiazoliloacetamido-cefalosporanowego
JPS5479300A (en) Method of manufacturing sodium salt of aminopectin sulfate
PL200062A1 (pl) Sposob wytwarzania pochodnych kwasu alfa-arylopropionowego